Urinary Retention: Clinical Trials

4 trials for Urinary Retention, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed. 4 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 44Completed 4

Follow Urinary Retention: new trials by email Literature Review of Urinary Retention trials Research Report on Urinary Retention

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Sugammadex vs Neostigmine/Glycopyrrolate on Urinary Retention After Spine Surgery
Sugammadex, Neostigmine, Glycopyrrolate - Spine Surgery, Reversal of Neuromuscular Blockade
Phase 4CompletedUniversity of Missouri-Columbia1182023-08-032026-10-07
Prevention of Postoperative Urinary Retention With Treatment of Tamsulosin 5 Days Prior to Lower Limb Arthroplasty
Tamsulosin, Placebo Oral Tablet - Urinary Retention Postoperative, Arthropathy of Knee
Phase 4CompletedKantonsspital Graubünden1702019-08-012025-09-03
Assessing Pyridium for Post-Sling Urinary Retention
Phenazopyridine - Urinary Retention
Phase 4CompletedIcahn School of Medicine at Mount Sinai982017-10-242019-10-29
Nitrofurantoin Administration for the Prevention of Short-Term Catheter Associated Urinary Tract Infection After Pelvic Surgery
Nitrofurantoin 100 MG, Placebo Oral Tablet - Catheter-Associated Urinary Tract Infection
Phase 4CompletedWake Forest University Health Sciences1642017-09-292022-08-09

Narrower conditions

Pelvic Organ Prolapse (1)  ·  Prolapse (1)  ·  Urinary Tract Infections (1)

Broader conditions

Female Urogenital Diseases (4)  ·  Female Urogenital Diseases and Pregnancy Complications (4)  ·  Male Urogenital Diseases (4)  ·  Urination Disorders (4)  ·  Urogenital Diseases (4)  ·  Urologic Diseases (4)  ·  Infections (1)  ·  Pathological Conditions, Anatomical (1)  ·  Pathological Conditions, Signs and Symptoms (1)

Interventions

Glycopyrrolate (1)  ·  Neostigmine (1)  ·  Nitrofurantoin (1)  ·  Phenazopyridine (1)  ·  Rocuronium (1)  ·  Sugammadex (1)  ·  Tamsulosin (1)

Sponsors

Icahn School of Medicine at Mount Sinai (1)  ·  Kantonsspital Graubünden (1)  ·  University of Missouri-Columbia (1)  ·  Wake Forest University Health Sciences (1)

Countries

United States (3)  ·  Switzerland (1)

Top investigators

Boris Mraovic, MD, FASA (1)  ·  Charles Ascher-Walsh, M.D. (1)  ·  Dina Bastawros, MD (1)

Results publications

PMID 33620905